Cited by 924Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug ReactionsDrug-Induced Adverse Reactions

The DOI matches its Crossref record; 982 of the 982 references it cites were found in a registry or an index.

Drug-induced liver injury

Open access

Andrade, Raul J., Chalasani, Naga, Björnsson, Einar S., Suzuki, Ayako, Kullak-Ublick, Gerd A., Watkins, Paul B., Devarbhavi, Harshad, Merz, Michael, Lucena, M. Isabel, Kaplowitz, Neil, Aithal, Guruprasad P.·2019·Nature Reviews Disease Primers

DOI 10.1038/s41572-019-0105-0

Open this paper in CoChat — free account Open PDF

Abstract

Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that occurs either as a predictable event when an individual is exposed to toxic doses of some compounds or as an unpredictable event with many drugs in common use. Drugs can be harmful to the liver in susceptible individuals owing to genetic and environmental risk factors. These risk factors modify hepatic metabolism and excretion of the DILI-causative agent leading to cellular stress, cell death, activation of an adaptive immune response and a failure to adapt, with progression to overt liver injury. Idiosyncratic DILI is a relative rare hepatic disorder but can be severe and, in some cases, fatal, presenting with a variety of phenotypes, which mimic other hepatic diseases. The diagnosis of DILI relies on the exclusion of other aetiologies of liver disease as specific biomarkers are still lacking. Clinical scales such as CIOMS/RUCAM can support the diagnostic process but need refinement. A number of clinical variables, validated in prospective cohorts, can be used to predict a more severe DILI outcome. Although no pharmacological therapy has been adequately tested in randomized clinical trials, corticosteroids can be useful, particularly in the emergent form of DILI related to immune-checkpoint inhibitors in patients with cancer.

Integrity signals

Registry

Crossref · 10.1038/s41572-019-0105-0

Cites

982 of 982 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

2 of 2

2 retracted

Items 401–600 of 982

Serious Adverse Drug Reactions to Pyrimethamine-Sulphadoxine, Pyrimethamine-Dapsone and to Amodiaquine in Britain
Phillips‐Howard, P. A., & West, L. (1990) · Journal of the Royal Society of Medicine · doi:10.1177/014107689008300208 · Cited by 117
Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A
Marr, K. A., Hachem, R. Y., Papanicolaou, G. A., Somani, J., Arduino, J. M., Lipka, C. J., Ngai, A., Kartsonis, N. A., Chodakewitz, J., & Sable, C. (2004) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2004.00065.x · Cited by 117
Telithromycin‐associated hepatotoxicity
Brinker, A. D., Wassel, R. T., Lyndly, J., Serrano, J., Avigan, M., Lee, W. M., & Seeff, L. B. (2008) · Hepatology · doi:10.1002/hep.22620 · Cited by 116
Outcome of Liver Transplantation for Drug-Induced Acute Liver Failure in the United States: Analysis of the United Network for Organ Sharing Database
Mindikoglu, A. L., Magder, L. S., & Regev, A. (2009) · Liver Transplantation · doi:10.1002/lt.21692 · Cited by 116
Interactions Between Tacrolimus and Antimicrobial Agents
Paterson, D. L., & Singh, N. (1997) · Clinical Infectious Diseases · doi:10.1086/516138 · Cited by 116
Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001
Law, W. P., Dore, G. J., Duncombe, C. J., Mahanontharit, A., Boyd, M. A., Ruxrungtham, K., Lange, J. M. A., Phanuphak, P., & Cooper, D. A. (2003) · AIDS · doi:10.1097/00002030-200310170-00007 · Cited by 116
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis
Foureau, D., Walling, T. L., Maddukuri, V. C., Anderson, W. E., Culbreath, K., Kleiner, D. E., Ahrens, W. A., Jacobs, C., Watkins, P. B., Fontana, R. J., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12558 · Cited by 116
Self-citation
NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis [Review article]
Wang, P. F., Xie, S.-Y., Hao, Q., Zhang, C., & Jiang, B.-F. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0377 · Cited by 116
Hepatotoxicity of the thiazolidinediones
Tolman, K. G., & Chandramouli, J. C. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00020-5 · Cited by 115
METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
He, K., Talaat, R. E., Pool, W. F., Reily, M. D., Reed, J. E., Bridges, A. J., & Woolf, T. F. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.639 · Cited by 115
Silencing Glycogen Synthase Kinase-3β Inhibits Acetaminophen Hepatotoxicity and Attenuates JNK Activation and Loss of Glutamate Cysteine Ligase and Myeloid Cell Leukemia Sequence 1
Shinohara, M., Ybanez, M. D., Win, S., Than, T. A., Jain, S., Gaarde, W. A., Han, D., & Kaplowitz, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054999 · Cited by 114
Self-citation
Efficacy of pergolide in treatment of restless legs syndrome
Trenkwalder, C., Hundemer, H., Lledó, A., Swieca, J., Polo, O. J., Wetter, T. C., Ferini‐Strambi, L., de Groen, H., Quail, D., & Brandenburg, U. (2004) · Neurology · doi:10.1212/01.wnl.0000124465.20878.84 · Cited by 113
The role of non-steroidal anti-inflammatory drugs in acute liver injury.
Rodriguez, L. A. G., Perez‐Gutthann, S., Walker, A. M., & Lueck, L. (1992) · BMJ · doi:10.1136/bmj.305.6858.865 · Cited by 113
Hepatotoxicity of antiretroviral therapy.
Kontorinis, N., & Dieterich, D. T. (2003) · PubMed · Cited by 112
Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH)
Watkins, P. B., Desai, M. G., Berkowitz, S. D., Peters, G. R., Horsmans, Y., Larrey, D. G., & Maddrey, W. C. (2011) · Drug Safety · doi:10.2165/11586600-000000000-00000 · Cited by 109
Self-citation
Role of neutrophils in a mouse model of halothane-induced liver injury
You, Q., Cheng, L., Reilly, T. P., Wegmann, D. R., & Ju, C. (2006) · Hepatology · doi:10.1002/hep.21425 · Cited by 109
Antineoplastic agents and the liver
Ménard, D. B., Gisselbrecht, C., Marty, M. E., Reyes, F., & Dhumeaux, D. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90205-x · Cited by 109
The liver–gut microbiota axis modulates hepatotoxicity of tacrine in the rat
Yip, L. Y., Aw, C. C., Lee, S. H., Hong, Y., Ku, H. C., Xu, W. H., Chan, M. X. J., Cheong, E. J. Y., Chng, K. R., Ng, A. H. Q., et al. (2017) · Hepatology · doi:10.1002/hep.29327 · Cited by 109
Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues
Chai, C., Rivkin, M., Berkovits, L., Simerzin, A., Zorde‐Khvalevsky, E., Rosenberg, N., Klein, S., Yaish, D., Durst, R. Y., Shpitzen, S., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.013 · Cited by 109
Safety and Tolerability of Fluconazole in Children
Novelli, V. M., & Holzel, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1955 · Cited by 108
Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations.
Haboubi, N. Y., Hh, A., Whitwell, H., & Ackrill, P. (1988) · PubMed · Cited by 108
Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury
Ortega‐Alonso, A., Stephens, C. M., Lucena, M. I., & Andrade, R. J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050714 · Cited by 108
Self-citation
Persistent Liver Biochemistry Abnormalities Are More Common in Older Patients and those With Cholestatic Drug Induced Liver Injury
Fontana, R. J., Hayashi, P. H., Barnhart, H. X., Kleiner, D. E., Reddy, K. R., Chalasani, N., Lee, W. M., Stolz, A., Phillips, T. A., Serrano, J., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.283 · Cited by 107
Self-citation
Section 4 Adverse reactions to non-steroidal antirheumatic drugs
Cuthbert, M. F. (1974) · Current Medical Research and Opinion · doi:10.1185/03007997409115265 · Cited by 107
Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients
Zhou, Y., Yang, L., Liao, Z., He, X., Zhou, Y., & Guo, H. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835f6889 · Cited by 107
Valproate therapy and nonalcoholic fatty liver disease
Luef, G. J., Waldmann, M., Sturm, W., Naser, A., Trinka, E., Unterberger, I., Bauer, G. J., & Lechleitner, M. (2004) · Annals of Neurology · doi:10.1002/ana.20074 · Cited by 107
Incidence of Statin Hepatotoxicity in Patients With Hepatitis C
Khorashadi, S., Hasson, N. K., & Cheung, R. C. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.014 · Cited by 107
The transformation in biomarker detection and management of drug‐induced liver injury
Church, R. J., & Watkins, P. B. (2017) · Liver International · doi:10.1111/liv.13441 · Cited by 107
Self-citation
Metabolism of Lamotrigine to a Reactive Arene Oxide Intermediate
Maggs, J. L., Naisbitt, D. J., Tettey, J. N. A., Pirmohamed, M., & Park, B. K. (2000) · Chemical Research in Toxicology · doi:10.1021/tx0000825 · Cited by 106
Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial
Staedke, S. G., Mpimbaza, A., Kamya, M. R., Nzarubara, B., Dorsey, G., & Rosenthal, P. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17478-3 · Cited by 105
PREVENTION OF WOUND INFECTION IN ACUTE APPENDICITIS
Benson, E. A. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91076-3 · Cited by 105
Acetaminophen Metabolism Does Not Contribute to Gender Difference in Its Hepatotoxicity in Mouse
Dai, G., He, L., Chou, N., & Wan, Y. Y. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj192 · Cited by 104
Hepatotoxicity after Desflurane Anesthesia
Martin, J. L., Plevak, D. J., Flannery, K. D., Charlton, M., Poterucha, J. J., Humphreys, C. E., Derfus, G. A., & Pohl, L. R. (1995) · Anesthesiology · doi:10.1097/00000542-199511000-00030 · Cited by 104
Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo*
Mitra, A., Thummel, K. E., Kalhorn, T. F., Kharasch, E. D., Unadkat, J. D., & Slattcry, J. T. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90176-0 · Cited by 104
Premature aging and immune senescence in HIV-infected children
Gianesin, K., Noguera‐Julián, A., Zanchetta, M., Bianco, P. D., Petrara, M. R., Freguja, R., Rampon, O., Fortuny, C., Camós, M., Mozzo, E., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001093 · Cited by 104
Acetaminophen hepatotoxicity: An update
McClain, C. J., Price, S., Barve, S. S., Devalarja, R., & Shedlofsky, S. I. (1999) · Current Gastroenterology Reports · doi:10.1007/s11894-999-0086-3 · Cited by 103
On the path to the heat shock response: destabilization and formation of partially folded protein intermediates, a consequence of protein thiol modification
Freeman, M. L., Borrelli, M. J., Meredith, M. J., & Lepock, J. R. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00258-5 · Cited by 103
Safety of Tacrine: Clinical Trials, Treatment IND, and Postmarketing Experience
Gracon, S. I., Knapp, M. J., Berghoff, W. G., Pierce, M., DeJong, R., Lobbestael, S. J., Symons, J. P., Dombey, S., Luscombe, F. A., & Kraemer, D. F. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199806000-00007 · Cited by 103
Quinidine and Haloperidol as Modifiers of CYP3A4 Activity: Multisite Kinetic Model Approach
Galetin, A., Clarke, S. E., & Houston, J. B. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.12.1512 · Cited by 103
Amiodarone-induced hepatic phospholipidosis: A morphological alteration independent of pseudoalcoholic liver disease
Guigui, B., Perrot, S., Berry, J. P., Fleury‐Feith, J., Martin, N., Métreau, J., Dhumeaux, D., & Zafrani, É. S. (1988) · Hepatology · doi:10.1002/hep.1840080514 · Cited by 103
Acetaminophen‐related acute liver failure in the United States
Lee, W. M. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00419.x · Cited by 102
A retrospective pooled analysis of duloxetine safety in 23 983 subjects
Gahimer, J., Wernicke, J., Yalcin, I., Ossanna, M. J., Wulster-Radcliffe, M. C., & Viktrup, L. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x162719 · Cited by 102
Effects of Modifying Structure on Electrophilic Reactions with Biological Nucleophiles
Coles, B. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409029962 · Cited by 102
Drug-induced liver injury and drug development: industry perspective
Regev, A. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1375962 · Cited by 102
The management of anti-tuberculosis drug-induced hepatotoxicity.
Tahaoğlu, K., Ataç, G., Sevim, T., Tärün, T., Yazıcıoğlu, Ö. M., Horzum, G., Gemci, I., Ongel, A., Kapaklı, N., & Aksoy, E. (2001) · PubMed · Cited by 102
Beneficial hemodynamic effects of bosentan, a mixed ETA and ETB receptor antagonist, in portal hypertensive rats
Sogni, P., Moreau, R., Gomola, A., Gadano, A. C., Cailmail, S., Calmus, Y., Clozel, M., & Lebrec, D. (1998) · Hepatology · doi:10.1002/hep.510280308 · Cited by 101
Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy
Ben‐Menachem, E., & Gilland, E. (2002) · Seizure · doi:10.1016/s1059-1311(02)00251-0 · Cited by 101
Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.
Deschamps, D., Fisch, C., Fromenty, B., Berson, A., Degott, C., & Pessayre, D. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20562-6 · Cited by 101
Mechanisms of idiosyncratic drug reactions: the case of felbamate
Dieckhaus, C. M., Thompson, C. D., Roller, S. G., & Macdonald, T. L. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00057-1 · Cited by 100
Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?
Gauci, M.-L., Baroudjian, B., Zeboulon, C., Pagès, C., Poté, N., Roux, O., Bouattour, M., & Lebbé, C. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.034 · Cited by 100
The hepatotoxicity of non‐steroidal anti‐inflammatory drugs
Rubenstein, J. H., & Laine, L. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02092.x · Cited by 99
HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity
Stephens, C. M., López‐Nevot, M. Á., Ruiz‐Cabello, F., Ulzurrun, E., Soriano, G., Romero‐Gómez, M., Moreno-Casares, A., Lucena, M. I., & Andrade, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068111 · Cited by 99
Self-citation
Ultrastructural Changes during Acute Acetaminophen-Induced Hepatotoxicity in the Mouse: A Time and Dose Study
Placke, M. E., Ginsberg, G. L., Wyand, D. S., & Cohen, S. D. (1987) · Toxicologic Pathology · doi:10.1177/019262338701500407 · Cited by 99
Potential for Interactions between Caspofungin and Nelfinavir or Rifampin
Stone, J. A., Migoya, E. M., Hickey, L., Winchell, G. A., Deutsch, P., Ghosh, K., Freeman, A., Bi, S., Desai, R., Dilzer, S. C., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4306-4314.2004 · Cited by 99
A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein
Pumford, N. R., Martin, B. M., & Hinson, J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91881-p · Cited by 98
Hepatotoxicity Fears Contribute to Underutilization of Statin Medications by Primary Care Physicians
Rzouq, F. S., Volk, M. L., Hatoum, H. H., Talluri, S., Mummadi, R. R., & Sood, G. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181e15da8 · Cited by 98
Impact of Chronic Hepatitis B Virus (HBV) Infection on Outcomes of Patients Infected with HIV in an Area Where HBV Infection Is Hyperendemic
Sheng, W., Chen, M.-Y., Hsieh, S., Hsiao, C., Wang, J., Hung, C., & Chang, S. (2004) · Clinical Infectious Diseases · doi:10.1086/420744 · Cited by 98
Liver Enzyme Induction and Serum Lipid Levels After Replacement of Carbamazepine with Oxcarbazepine
Isojärvi, J. I. T., Pakarinen, A., Rautio, A., Pelkonen, O., & Myllylä, V. V. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb01792.x · Cited by 98
ADVERSE EFFECTS OF VOLATILE ANAESTHETICS
Brown, B. R., & Gandolfi, A. J. (1987) · British Journal of Anaesthesia · doi:10.1093/bja/59.1.14 · Cited by 98
An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro
Pirmohamed, M., Kitteringham, N. R., Guenthner, T. M., Breckenridge, A. M., & Park, B. K. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90696-g · Cited by 97
Hepatotoxicity associated with sustained-release niacin
Dalton, T. A., & Berry, R. S. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90689-9 · Cited by 97
Fulminant hepatic failure associated with the use of black cohosh: A case report
Lynch, C. R., Folkers, M. E., & Hutson, W. R. (2006) · Liver Transplantation · doi:10.1002/lt.20778 · Cited by 96
Dissociation of cell death from covalent binding of paracetamol by flavones in a hepatocyte system
Devalia, J. L., Ogilvie, R. C., & McLean, A. E. M. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90287-8 · Cited by 96
Mechanism-Based Inactivation of Human Cytochrome P4502C8 by Drugs in Vitro
Polasek, T. M., Elliot, D. J., Lewis, B. C., & Miners, J. O. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071803 · Cited by 96
Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity
Liu, J., Liu, Y., Klaassen, C. D., Shehin, S. E., Lucas, A., & Cohen, S. D. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8847-9_81 · Cited by 96
Toxicity of Non-Nucleoside Analogue Reverse Transcriptase Inhibitors
Kontorinis, N., & Dieterich, D. T. (2003) · Seminars in Liver Disease · doi:10.1055/s-2003-39948 · Cited by 95
The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects
Niemi, M., Kajosaari, L. I., Neuvonen, M., Backman, J. T., & Neuvonen, P. J. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.02027.x · Cited by 95
Atorvastatin associated liver disease
Clarke, A. T., & Mills, P. R. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.04.013 · Cited by 94
Complications of Hepatic Artery Infusion : A Review of 4580 Reported Cases
Barnett, K. T., & Malafa, M. P. (2001) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:30:3:147 · Cited by 94
ACUTE LIFE-THREATENING TOXICITY OF CANCER TREATMENT
Shanholtz, C. B. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70196-2 · Cited by 93
Sulindac-associated hepatic injury: Analysis of 91 cases reported to the food and drug administration
Tarazi, E. M., Harter, J. G., Zimmerman, H. J., Ishak, K. G., & Eaton, R. A. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90428-f · Cited by 92
Dapsone toxicity: Some current perspectives
Coleman, M. D. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00029-1 · Cited by 92
On the role of thiol groups in the inhibition of liver microsomal ca2+ sequestration by toxic agents
Thor, H., Hartzell, P., Svensson, S.-Å., Orrenius, S., Mirabelli, F., Marinoni, V., & Bellomo, G. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90236-9 · Cited by 92
Minocycline-Related Autoimmune Hepatitis
Teitelbaum, J. E., Pérez‐Atayde, A. R., Cohen, M. S., Bousvaros, A., & Jonas, M. M. (1998) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.152.11.1132 · Cited by 92
Paracetamol-induced hepatic necrosis in the mouse—Relationship between covalent binding, hepatic glutathione depletion and the protective effect of α-mercaptopropionylglycine
Labadarios, D., Davis, M. R., Portmann, B. C., & Williams, R. L. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90126-5 · Cited by 92
Changing Patterns in Causes of Death in a Cohort of Injecting Drug Users, 1980-2001
Copeland, L., Budd, J., Robertson, J. R., & Elton, R. A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.11.1214 · Cited by 92
Reactive intermediates and their toxicological significance
Monks, T. J., & Lau, S. S. (1988) · Toxicology · doi:10.1016/0300-483x(88)90195-3 · Cited by 91
Azathioprine hypersensitivity-like reations-a case report and a review of the literature
Knowles, S. R., GUTPTA, A. K., Shear, N. H., & Dn, S. (1995) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1995.tb01343.x · Cited by 91
Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice
Church, R. J., Gatti, D. M., Urban, T. J., Long, N., Yang, X., Shi, Q., Eaddy, J. S., Mosedale, M., Ballard, S., Churchill, G. A., et al. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.11.008 · Cited by 90
Self-citation
Niacin-Induced Hepatitis: A Potential Side Effect With Low-Dose Time-Release Niacin
Etchason, J., Miller, T. D., Squires, R. W., Allison, T. G., Gau, G. T., Marttila, J. K., & Kottke, B. A. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61171-9 · Cited by 90
Assessing methods for causality assessment of suspected adverse drug reactions
Hutchinson, T. A., & Lane, D. A. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90020-6 · Cited by 89
Reversal of acetaminophen toxicity in isolated hamster hepatocytes by dithiothreitol
Tee, L. B. G. (1986) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(86)90307-8 · Cited by 89
Autoimmune hepatitis revealed by atorvastatin
Pelli, N., Setti, M., Ceppa, P., Toncini, C., & Indiveri, F. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200308000-00014 · Cited by 89
Pharmacokinetics of Rifapentine at 600, 900, and 1,200 mg during Once-Weekly Tuberculosis Therapy
WEINER, M. H., BOCK, N. N., Peloquin, C. A., Burman, W. J., Khan, A., Vernon, A. A., Zhao, Z., Weis, S. E., Sterling, T. R., Hayden, K., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200311-1612oc · Cited by 89
Felbamate‐associated fatal acute hepatic necrosis
O’Neil, M. G., Perdun, C. S., Wilson, M., McGown, S. T., & Patel, S. (1996) · Neurology · doi:10.1212/wnl.46.5.1457 · Cited by 89
Herb-Induced Liver Injuries in Developing Nations: An Update
Obasi, C. N., & Orisakwe, O. E. (2018) · Toxics · doi:10.3390/toxics6020024 · Cited by 89
Elevation of Hepatic Transaminases after Enoxaparin Use: Case Report and Review of Unfractionated and Low‐Molecular‐Weight Heparin‐Induced Hepatotoxicity
Carlson, M. K., Gleason, P. P., & Sen, S. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.1.108.34436 · Cited by 88
Acetaminophen-induced hepatotoxicity in mice.
Walker, R. M., Racz, W. J., & McElligott, T. F. (1980) · PubMed · Cited by 88
Hepatotoxicity Associated with Antiretroviral Therapy Containing HIV-1 Protease Inhibitors
Sulkowski, M. (2003) · Seminars in Liver Disease · doi:10.1055/s-2003-39949 · Cited by 87
Effect of aspirin on liver tests in patients with ra or sle and in normal volunteers
Seaman, W. E., & Plötz, P. H. (1976) · Arthritis & Rheumatism · doi:10.1002/art.1780190205 · Cited by 87
Consecutive action of phospholipase A2 and glutathione peroxidase is required for reduction of phospholipid hydroperoxides and provides a convenient method to determine peroxide values in membranes
van Kuijk, F. J. G. M., Handelman, G. J., & Dratz, E. A. (1985) · Journal of Free Radicals in Biology & Medicine · doi:10.1016/0748-5514(85)90156-4 · Cited by 87
Outcome and determinants of mortality in 269 patients with combination anti‐tuberculosis drug‐induced liver injury
Devarbhavi, H., Singh, R., Patil, M., Sheth, K., Adarsh, C. K., & Balaraju, G. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07279.x · Cited by 86
Self-citation
Glutamate dehydrogenase: biochemical and clinical aspects of an interesting enzyme
Schmidt, E. S., & Schmidt, F. W. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90356-7 · Cited by 86
Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.
Rau, R., Karger, T., Herborn, G., & Frenzel, H. (1989) · PubMed · Cited by 85
Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic
Barker, J. N., Horn, E. J., Lebwohl, M., Warren, R. B., Nast, A., Rosenberg, W. M., & Smith, C. H. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03932.x · Cited by 85
Caspofungin: first approved agent in a new class of antifungals
Johnson, M. D., & Perfect, J. R. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.5.807 · Cited by 85
Sex Differences in Liver Toxicity—Do Female and Male Human Primary Hepatocytes React Differently to Toxicants In Vitro?
Mennecozzi, M., Landesmann, B., Palosaari, T., Harris, G., & Whelan, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122786 · Cited by 85
Antidepressant-lnduced Liver Injury
DeSanty, K. P., & Amabile, C. M. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k114 · Cited by 85
Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients
Jain, A. B., Venkataramanan, R., Eghtesad, B., Marcos, A., Ragni, M., Shapiro, R., Rafail, A. B., & Fung, J. J. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50171 · Cited by 85
N-Deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes
Rodríguez, R. L. (1997) · Toxicology · doi:10.1016/s0300-483x(96)03560-3 · Cited by 85
Purification, antibody production, and partial amino acid sequence of the 58-kDa acetaminophen-binding liver proteins
Bartolone, J. B., Birge, R. B., Bulera, S. J., Bruno, M. K., Nishanian, E. V., Cohen, S. D., & Khairallah, E. A. (1992) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(92)90004-c · Cited by 84
Drug-Induced liver injury with hypersensitivity features has a better outcome: A single-center experience of 39 children and adolescents
Devarbhavi, H. C., Karanth, D., Prasanna, K. S., Adarsh, C. K., & Patil, M. (2011) · Hepatology · doi:10.1002/hep.24527 · Cited by 84
Self-citation
Fulminant Liver Failure Associated with the Use of Black Cohosh
Levitsky, J., Alli, T. A., Wisecarver, J. L., & Sorrell, M. F. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2470-7 · Cited by 84
Flucytosine: Correlation between Toxicity and Pharmacokinetic Parameters
Vermes, A., van der Sijs, H., & Guchelaar, H. (2000) · Chemotherapy · doi:10.1159/000007260 · Cited by 84
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole
Ullmann, A. J. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125001884 · Cited by 84
Hepatic Injury During Ketoconazole Therapy in Patients With Onychomycosis: A Controlled Cohort Study
Chien, R.-N., Yang, L., Lin, P., & Liaw, Y. (1997) · Hepatology · doi:10.1002/hep.510250119 · Cited by 83
Liver injury associated with the β-interferons for MS
Tremlett, H. L., Yoshida, E. M., & Oger, J. (2004) · Neurology · doi:10.1212/wnl.62.4.628 · Cited by 83
Veno-occlusive disease of the liver in children treated for Wilms tumor
Bisogno, G., de Kraker, J., Weirich, A., Masiero, L., Ludwig, R., Tournade, M. F., & Carli, M. (1997) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199710)29:4 · Cited by 83
Drug-Induced Hepatic Steatosis
Chalasani, N., & Amacher, D. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1375960 · Cited by 83
Self-citation
Clinical characteristics and prognostic markers in disulfiram-induced liver injury
Bjornsson, E. S., Nordlinder, H., & Olsson, R. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.016 · Cited by 82
Itraconazole-Induced Cholestasis: Involvement of the Inhibition of Bile Canalicular Phospholipid Translocator MDR3/ABCB4
Yoshikado, T., Takada, T., Yamamoto, T., Yamaji, H., Ito, K., Santa, T., Yokota, H., Yatomi, Y., Yoshida, H., Goto, J., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.067256 · Cited by 82
Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats
Bolder, U., Trang, N. V., Hagey, L. R., Schteingart, C. D., Ton‐Nu, H., Cerré, C., Elferink, R. P. J. O., & Hofmann, A. F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70356-2 · Cited by 82
Risk Factors for Hepatotoxicity in Patients Treated With Highly Active Antiretroviral Therapy
Bonfanti, P., Landonio, S., Ricci, E. D., Martinelli, C. V., Fortuna, P., Faggion, I., & Quirino, T. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200107010-00017 · Cited by 82
Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications
Kaliyaperumal, K., Grove, J. I., Delahay, R. M., Griffiths, W. J., Duckworth, A., & Aithal, G. P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.013 · Cited by 82
Self-citation
Fulminant hepatic failure induced by lamotrigine
Makin, A. J., Fitt, S., & Williams, R. L. (1995) · BMJ · doi:10.1136/bmj.311.7000.292b · Cited by 81
Elevated cytosolic calcium in rat hepatocytes exposed to carbon tetrachloride.
Long, R. M., & Moore, L. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24874-1 · Cited by 81
Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone
Graham, D. J., Drinkard, C. R., & Shatin, D. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05843-4 · Cited by 81
Mortality due to Liver Failure and Impact on Survival of Hepatitis Virus Infections in HIV-Infected Patients Receiving Potent Antiretroviral Therapy
Macı́as, J., Melguizo, I., Fernández-Rivera, F., García-García, A., Mira, J., Ramos, A. J., Rivera, J., & Pineda, J. A. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0823-0 · Cited by 81
Hepatotoxicity of Mercaptopurine
Shorey, J. W. (1968) · Archives of Internal Medicine · doi:10.1001/archinte.1968.00300060056011 · Cited by 81
Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity
Hoff, P. M., Saad, E. D., Costa, F. P., Coutinho, A. K., Caponero, R., Prolla, G., & Gansl, R. C. (2011) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2011.10.004 · Cited by 81
Halogenated inhalational anaesthetics
Reichle, F. M., & Conzen, P. (2003) · Best practice & research. Clinical anaesthesiology · doi:10.1053/bean.2002.0265 · Cited by 80
Immune mechanisms in tienilic acid associated hepatotoxicity.
Neuberger, J., & Williams, R. L. (1989) · Gut · doi:10.1136/gut.30.4.515 · Cited by 80
Possible role of HLA in hepatotoxicity
Berson, A., Fréneaux, E., Larrey, D. G., Lepage, V., Douay, C., Mallet, C., Fromenty, B., Benhamou, J., & Pessayre, D. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80004-9 · Cited by 79
Hepatotoxicity of Tacrine: Occurrence of Membrane Fluidity Alterations without Involvement of Lipid Peroxidation
Galisteo, M., Rissel, M., Sergent, O., Chevanne, M., Cillard, J., Guillouzo, A., & Lagadic‐Gossmann, D. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39052-4 · Cited by 79
A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma
Kemeny, N. E., Childs, B., Larchian, W. A., Rosado, K., & Kelsen, D. P. (1990) · Cancer · doi:10.1002/1097-0142(19900815)66:4 · Cited by 79
Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system
Askmark, H., & Wiholm, B. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1990.tb00949.x · Cited by 79
Profiles of Serum Cytokines in Acute Drug-Induced Liver Injury and Their Prognostic Significance
Steuerwald, N., Foureau, D., Norton, H. J., Zhou, J., Parsons, J. C., Chalasani, N., Fontana, R. J., Watkins, P. B., Lee, W. M., Reddy, K. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081974 · Cited by 79
Self-citation
Topiramate Enhances the Risk of Valproate‐associated Side Effects in Three Children
Longin, E., Teich, M., Koelfen, W., & König, S. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.42401.x · Cited by 78
Effects of entacapone and tolcapone on mitochondrial membrane potential
Haasio, K., Koponen, A., Penttilä, K. E., & Nissinen, E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02383-x · Cited by 78
Hepatotoxicity of Antitubercular Treatments
Durand, F., Jébrak, G., Pessayre, D., Fournier, M., & Bernuau, J. (1996) · Drug Safety · doi:10.2165/00002018-199615060-00004 · Cited by 78
Amoxicillin-clavulanic acid therapy may be associated with severe side effects -- review of the literature.
Gresser, U. (2001) · PubMed · Cited by 78
Duloxetine hepatotoxicity: a case‐series from the drug‐induced liver injury network
Vuppalanchi, R., Hayashi, P. H., Chalasani, N., Fontana, R. J., Bonkovsky, H. L., Saxena, R., Kleiner, D. E., Hoofnagle, J. H., & the Drug‐Induced Liver Injury Network (DILIN) (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04449.x · Cited by 77
Self-citation
Drug-Induced Allergic Hepatitis
Pohl, L. (1990) · Seminars in Liver Disease · doi:10.1055/s-2008-1040486 · Cited by 77
Effects of Age and Polytherapy, Risk Factors of Valproic Acid (VPA) Hepatotoxicity, on the Excretion of Thiol Conjugates of (E)‐2,4‐diene VPA in People with Epilepsy Taking VPA
Gopaul, S., Farrell, K., & Abbott, F. S. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.07202.x · Cited by 77
Adverse Effects of Antiepileptic Drugs
Toledano, R., & Gil‐Nagel, A. (2008) · Seminars in Neurology · doi:10.1055/s-2008-1079336 · Cited by 77
Specific adverse effects of antiepileptic drugs — A true-to-life monotherapy study
Kowski, A. B., Weissinger, F., Gaus, V., Fidzinski, P., Losch, F., & Holtkamp, M. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.11.009 · Cited by 77
Hepatotoxicity Associated with the Use of Anti-TNF-α Agents
French, J. B., Bonacini, M., Ghabril, M., Foureau, D., & Bonkovsky, H. L. (2015) · Drug Safety · doi:10.1007/s40264-015-0366-9 · Cited by 77
Imatinib-induced fatal acute liver failure
Ridruejo, E., Cacchione, R., Villamil, A. G., Marciano, S., Gadano, A. C., & Mandó, O. G. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i48.6608 · Cited by 76
Antituberculosis treatment-induced hepatotoxicity: role of predictive factors
Singh, J., Arora, A., Garg, P. K., Thakur, V. S., Pande, J. N., & Tandon, R. K. (1995) · Postgraduate Medical Journal · doi:10.1136/pgmj.71.836.359 · Cited by 76
An evaluation of potential mechanism‐based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid
Polasek, T. M., Elliot, D. J., Somogyi, A. A., Gillam, E. M. J., Lewis, B. C., & Miners, J. O. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02627.x · Cited by 76
The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected].
Galan, M. V., Potts, J. A., Silverman, A. L., & Gordon, S. C. (2005) · PubMed · Cited by 75
The Morphologic Spectrum of Halothane–Induced Hepatic Injury: Analysis of 77 Cases
Benjamin, S. B., Goodman, Z. D., Ishak, K. G., Zimmerman, H. J., & Irey, N. S. (1985) · Hepatology · doi:10.1002/hep.1840050617 · Cited by 75
Risk factors for antituberculous chemotherapy‐induced hepatotoxicity in Japanese pediatric patients
Ohkawa, K., Hashiguchi, M., Ohno, K., Chikako, K., Takahashi, S., Kondo, S., Echizen, H., & Ogata, H. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.126175 · Cited by 74
In Vivo CYP3A4 Heteroactivation Is a Possible Mechanism for the Drug Interaction between Felbamate and Carbamazepine
Egnell, A., Houston, B., & Boyer, S. K. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047530 · Cited by 74
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database
Raschi, E., Poluzzi, E., Koci, A., Caraceni, P., & Ponti, F. D. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i8.601 · Cited by 73
Inhibitory Effect of Antituberculosis Drugs on Human Cytochrome P450-Mediated Activities
Nishimura, Y., Kurata, N., Sakurai, E., & Yasuhara, H. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0040296 · Cited by 73
Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome
Pachkoria, K., Lucena, M. I., Crespo, E., Ruiz‐Cabello, F., López-Ortega, S., Fernández‐Santaella, M. C., Romero‐Gómez, M., Madrazo, A., Durán, J. A., de Dios, A. M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.017 · Cited by 73
Self-citation
Role of immune reactions in drug-induced liver injury (DILI)
Ju, C., & Reilly, T. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.645579 · Cited by 73
Liver injury from cyclosporine A
Kassianides, C., Nussenblatt, R. B., Palestine, A. G., Mellow, S. D., & Hoofnagle, J. H. (1990) · Digestive Diseases and Sciences · doi:10.1007/bf01540169 · Cited by 73
Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis
Suissa, S., Ernst, P., Hudson, M., Bitton, A., & Kezouh, A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.032 · Cited by 73
Diurnal Variation in Mouse and Rat Liver Sulfhydryl.
Beck, L. V., Rieck, V. D., & Duncan, B. B. (1958) · Experimental Biology and Medicine · doi:10.3181/00379727-97-23698 · Cited by 73
The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions
Kovacsics, D., Patik, I., & Özvegy-Laczka, C. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1253679 · Cited by 73
Liver Toxicity of Antiretroviral Drugs
Jones, M., & Núñez, M. (2012) · Seminars in Liver Disease · doi:10.1055/s-0032-1316472 · Cited by 72
Tacrine
Blackard, W. G., Sood, G., Crowe, D. R., & Fallon, M. B. (1998) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199801000-00015 · Cited by 72
Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD
Nakajima, T., Moriguchi, M., Katagishi, T., Sekoguchi, S., Nishikawa, T., Takashima, H., Kimura, H., Minami, M., Itoh, Y., Kagawa, K., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01178.x · Cited by 72
Lacrimal gland malignant mixed tumors (carcinomas arising in benign mixed tumors): A clinico-pathologic study
Perzin, K. H., Jakobiec, F. A., LiVolsi, V. A., & Desjardins, L. (1980) · Cancer · doi:10.1002/1097-0142(19800515)45:10 · Cited by 71
HLA Antigens in Patients with Unexplained Hepatitis following Halothane Anesthesia
Otsuka, S., Yamamoto, M., KASUYA, S., Ohtomo, H., YAMAMOTO, Y., Yoshida, T., & Akaza, T. (1985) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1985.tb02242.x · Cited by 71
Midazolam α‐Hydroxylation by Human Liver Microsomesin vitro: Inhibition by Calcium Channel Blockers, Itraconazole and Ketoconazole
Wang, J., Wen, X., Backman, J. T., Taavitsainen, P., Neuvonen, P. J., & Kivistö, K. T. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb00085.x · Cited by 71
Sevoflurane Hepatotoxicity: A Case Report of Sevoflurane Hepatic Necrosis and Review of the Literature
Singhal, S., Gray, T., Guzman, G., Verma, A., & Anand, K. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318197eacb · Cited by 71
Metformin-induced Acute Hepatitis
Babich, M., Pike, I. M., & Shiffman, M. L. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00088-6 · Cited by 71
Searching for a Needle in a Haystack: Use of ICD-9-CM Codes in Drug-Induced Liver Injury
Jinjuvadia, K., Kwan, W., & Fontana, R. J. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01456.x · Cited by 71
Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry.
Perdices, E. V., Medina‐Cáliz, I., Hernando, S., Ortega, A., Martín-Ocaña, F., Navarro, J. M., Peláez, G. I. C., Castiella, A., Hallal, H., Romero‐Gómez, M., et al. (2014) · PubMed · Cited by 71
Self-citation
Pharmacogenetic testing in idiosyncratic drug‐induced liver injury: current role in clinical practice
Aithal, G. P. (2015) · Liver International · doi:10.1111/liv.12836 · Cited by 70
Self-citation
Terbinafine-Associated Hepatotoxicity
Ajit, C., Zaeri, N., Muñoz, S. J., & Suvannasankha, A. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200305000-00008 · Cited by 70
Diclofenac-Induced Inactivation of CYP3A4 and Its Stimulation by Quinidine
Masubuchi, Y., Ose, A., & Horie, T. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.10.1143 · Cited by 70
Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.
Fisher, B., Keenan, A. M., Garra, B. S., Steinberg, S. M., White, D. E., DIBISCEGLIE, A., Hoofnagle, J. H., Yolles, P., Rosenberg, S. A., & Lotze, M. T. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.12.1852 · Cited by 70
Hepatotoxicity Associated with Acarbose Therapy
Hsiao, S., Liao, L.-H., Cheng, P., & Wu, T.-J. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g336 · Cited by 70
Acute liver failure in Scotland: changes in aetiology and outcomes over time (the Scottish Look‐Back Study)
Donnelly, M. C., Davidson, J. S., Martin, K. G., Baird, A. M., Hayes, P. C., & Simpson, K. J. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13943 · Cited by 70
Hepatotoxicity of Antimicrobial Agents
Brown, S., & Desmond, P. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30103 · Cited by 69
Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis.
Mion, F., Napoléon, B., Berger, F., Chevallier, M., Bonvoisin, S., & Descos, L. (1991) · Gut · doi:10.1136/gut.32.6.715 · Cited by 69
Tetracycline-induced bile duct paucity and prolonged cholestasis
Hunt, C. M., & Washington, K. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90830-3 · Cited by 68
Fatal Hepatitis Probably Due to Indomethacin
Kelsey, W. M. (1967) · JAMA · doi:10.1001/jama.1967.03120080120029 · Cited by 68
Safety of Nonsteroidal Anti-inflammatory Drugs With Respect to Acute Liver Disease
Carson, J. L. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.11.1331 · Cited by 68
Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the international consensus meeting
Takikawa, H. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00232-8 · Cited by 68
Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States
Hayashi, P. H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020201 · Cited by 68
Drug‐induced liver injury associated with stevens‐Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases
Devarbhavi, H. C., Raj, S., Venu, A., Rangegowda, V. T., Veeranna, G. P., Singh, R., Reddy, V., & Patil, M. (2015) · Hepatology · doi:10.1002/hep.28270 · Cited by 67
Self-citation
Captopril-Associated Cholestatic Jaundice
Rahmat, J., GELFAND, R. L., GELFAND, M. C., WINCHESTER, J. F., SCHREINER, G. E., & Zimmerman, H. J. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-1-56 · Cited by 67
The Hepatotoxicity of Antifungal Medications in Bone Marrow Transplant Recipients
Fischer, M. A., Winkelmayer, W. C., Rubin, R. H., & Avorn, J. (2005) · Clinical Infectious Diseases · doi:10.1086/431586 · Cited by 67
Drug‐induced hepatic injury in children: a case/non‐case study of suspected adverse drug reactions in VigiBase
Ferrajolo, C., Capuano, A., Verhamme, K. M. C., Schuemie, M. J., Rossi, F., Stricker, B. H. C., & Sturkenboom, M. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03754.x · Cited by 67
Adverse Drug Reactions to Gabapentin and Pregabalin
Fuzier, R., Serres, I., Bondon‐Guitton, E., Lapeyre‐Mestre, M., & Montastruc, J. (2012) · Drug Safety · doi:10.1007/s40264-012-0006-6 · Cited by 66
Anticonvulsant drug hypersensitivity.
Galindo, P. A., Borja, J., Gomez, E. V., Mur, P., Gudín, M., García, R., Encinas, C., Romero, G., Garrido, J. A., de la Calle, P. C., et al. (2002) · PubMed · Cited by 66
Risk of acute liver injury associated with the use of drugs: a multicentre population survey
Sabaté, M., Ibáñez, L., Pérez, E., Vidal, X., Buti, M., Xiol, X., Mas, A., Guarner, C., Forné, M., Sola, R. L., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03338.x · Cited by 66
Liver Injury Associated with Antidepressants
Park, S. J., & Ishino, R. (2013) · Current Drug Safety · doi:10.2174/1574886311308030011 · Cited by 66
A Role for the Pregnane X Receptor in Flucloxacillin-Induced Liver Injury
Andrews, E., Armstrong, M., Tugwood, J. D., Swan, D., Glaves, P. D., Pirmohamed, M., Aithal, G. P., Wright, M. C., Day, C. P., & Daly, A. K. (2010) · Hepatology · doi:10.1002/hep.23549 · Cited by 66
Self-citation
A Report of Hepatic Necrosis and Death Following Isoflurane Anesthesia
Carrigan, T. W., & Wj, S. (1987) · Anesthesiology · doi:10.1097/00000542-198710000-00026 · Cited by 66
Hepatopathy following irradiation and adriamycin
Kun, L. E., & Camitta, B. M. (1978) · Cancer · doi:10.1002/1097-0142(197807)42:1 · Cited by 66
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: The MOZART study
Sacchetti, E., Galluzzo, A., Valsecchi, P., Romeo, F., Gorini, B., & Warrington, L. E. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.02.017 · Cited by 66
Aggrenox: A Fixed-Dose Combination of Aspirin and Dipyridamole
Lenz, T. L., & Hilleman, D. E. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.10079 · Cited by 66
Drug‐induced acute liver failure in children and adults: Results of a single‐centre study of 128 patients
Devarbhavi, H. C., Patil, M., Reddy, V. V., Singh, R., Joseph, T., & Ganga, D. (2017) · Liver International · doi:10.1111/liv.13662 · Cited by 66
Self-citation
Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks
Biesecker, G., Karimi, S., Desjardins, J. P., Meyer, D. J., Abbott, B., Bendele, R., & Richardson, F. C. (2003) · Antiviral Research · doi:10.1016/s0166-3542(03)00005-6 · Cited by 65
Mitochondrial dysfunction in paracetamol hepatotoxicity: In vitro studies in isolated mouse hepatocytes
Burcham, P. C., & Harman, A. W. (1990) · Toxicology Letters · doi:10.1016/0378-4274(90)90250-p · Cited by 65
Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn's disease
Bataille, L., Rahier, J., & Geubel, A. P. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00268-4 · Cited by 65
Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment
Chakraborty, M., Fullerton, A. M., Semple, K., Chea, L. S., Proctor, W. R., Bourdi, M., Kleiner, D. E., Zeng, X., Ryan, P. M., Dagur, P. K., et al. (2015) · Hepatology · doi:10.1002/hep.27764 · Cited by 64
Erythromycin‐Associated Cholestatic Hepatitis
Derby, L. E., Jick, H., Henry, D. A., & Dean, A. D. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb137625.x · Cited by 64
Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature.
Eriksson, C., Gustavsson, A., Kronvall, T., & Tysk, C. (2011) · PubMed · Cited by 64
Case series of liver failure associated with rosiglitazone and pioglitazone
Floyd, J. S., Barbehenn, E. K., Lurie, P. G., & Wolfe, S. M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1804 · Cited by 64
Hepatotoxicity of Rifampin and Pyrazinamide in the Treatment of Latent Tuberculosis Infection in HIV-Infected Persons: Is It Different Than in HIV-Uninfected Persons?
Gordin, F. M., Cohn, D. L., Matts, J. P., Chaisson, R. E., & Brien, R. J. O. (2004) · Clinical Infectious Diseases · doi:10.1086/422724 · Cited by 64
Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™
Suzuki, A., Yuen, N., Ilić, K., Miller, R. T., Reese, M. J., Brown, H. R., Ambroso, J. L., Falls, J. G., & Hunt, C. M. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.05.004 · Cited by 63
Self-citation
Propofol Infusion Syndrome
Wong, J. M. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181ed837a · Cited by 63
Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: A safe and effective therapy?
Kuntzen, C., Gülberg, V., & Gerbes, A. L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.09.005 · Cited by 63

Research works printed but not linked: 3

Institute of Medicine. Exploring the Biological Contributions to Human Health: Does Sex Matter? (National Academies Press, 2001).
Sanjuan-Jimenez, R. et al. Prevalence of hepatitis E markers in Spanish patients with suspected drug-induced liver injury [abstract]. Hepatology 66, 423A (2017).
Abu-Sbeih, H., Styskel, B., Blechazz, B., Chalasani, N. & Miller, E. Clinically significant hepatotoxicity due to immune checkpoint inhibitors is rare but leads to treatment discontinuations in high proportion. Hepatology 68, 25A (2018).

Sorted by citations

ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Self-citation
Acute Pancreatitis: Diagnosis and Treatment
Szatmary, P., Grammatikopoulos, T., Cai, W., Huang, W., Mukherjee, R., Halloran, C. M., Beyer, G., & Sutton, R. (2022) · Drugs · doi:10.1007/s40265-022-01766-4 · Cited by 684
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Role of liver sinusoidal endothelial cells in liver diseases
Gracia‐Sancho, J., Caparrós, E., Fernández‐Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 436
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
Self-citation

See all 924

Authors: Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., & Aithal, G. P.
Affiliations: Indiana University School of Medicine (US)
Duke University (US)
Novartis (Switzerland) (CH)
University of North Carolina at Chapel Hill (US)
St.John's Medical College Hospital (IN)
University of Zurich (CH)
Spanish Clinical Research Network (ES)
Nottingham University Hospitals NHS Trust (GB)
Corresponding author: Lucena, M. Isabel
ORCID: Chalasani, Naga
Suzuki, Ayako
Kullak-Ublick, Gerd A.
Watkins, Paul B.
Devarbhavi, Harshad
Merz, Michael
Lucena, M. Isabel
Kaplowitz, Neil
Aithal, Guruprasad P.
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2019-08-22
Volume: 5
Issue: 1
Pages: 58-58
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-019-0105-0
OpenAlex: W1565605888
Cited by: 924
References: 982
Citations by year: 2026: 152 · 2025: 197 · 2024: 161 · 2023: 127 · 2022: 145 · 2021: 97 · 2020: 38
FWCI: 9.11
Type: journal article
Language: en
Open access: green
www.zora.uzh.ch
Licence: other-oa
www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by-nc-nd)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
Zurich Open Repository and Archive (University of Zurich)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
Keywords: drug-induced liver injury, idiosyncratic drug reactions, xenobiotic toxicity, genetic susceptibility, hepatic metabolism, immune response, corticosteroids, immune checkpoint inhibitors, hepatotoxicity
MeSH terms: Biopsy, Humans, Risk Factors, Biomarkers, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug-induced liver injury

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Cited works that were retracted

Citations

Cites

Cited by

Related

Metadata

Record

About these checks